Distinct roles of trauma and transfusion in induction of immune modulation after injury

Transfusion

Volumn 52, Issue 12, 2012, Pages 2533-2550

  Jackman, Rachael P ^a,b,c,d   Utter, Garth H ^a,b,c,d   Muench, Marcus O ^a,b,c,d   Heitman, John W ^a,b,c,d   Munz, Matthew M ^a,b,c,d   Jackman, Robert W ^a,b,c,d   Biswas, Hope H ^a,b,c,d   Rivers, Ryan M ^a,b,c,d   Tobler, Leslie H ^a,b,c,d   Busch, Michael P ^a,b,c,d   Norris, Philip J ^a,b,c,d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLUNT TRAUMA; COLLOID; CRYOPRECIPITATE; CRYSTALLOID; CYTOKINE RESPONSE; ERYTHROCYTE TRANSFUSION; FALLING; FEMALE; GUNSHOT INJURY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INJURY; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SPECIES COMPARISON; STAB WOUND; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE TRANSFUSION; TRAFFIC ACCIDENT; WOUND HEALING;

ACUTE DISEASE; ADULT; ANIMALS; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; MODELS, IMMUNOLOGICAL; STRESS, PHYSIOLOGICAL; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84871002847     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03618.x     Document Type: Article

References (93)

1. Hess JR, Hiippala S,. Optimizing the use of blood products in trauma care. Crit Care 2005; 9 Suppl 5: S10-4.
2. Trunkey DD,. History and development of trauma care in the United States. Clin Orthop Relat Res 2000;(374): 36-46.
3. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR,. Blood transfusion rates in the care of acute trauma. Transfusion 2004; 44: 809-13.
4. US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. 2011. Washington, DC: US Department of Health and Human Services.
5. Giannoudis PV,. Current concepts of the inflammatory response after major trauma: an update. Injury 2003; 34: 397 .
6. Mannick JA, Rodrick ML, Lederer JA,. The immunologic response to injury. J Am Coll Surg 2001; 193: 237-44.
7. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC,. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996; 40: 501-10; discussion 510-2.
8. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, Lopez MC, Klein MB, Gamelli RL, Tompkins RG, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581-90.
9. Foex BA, Lamb WR, Roberts TE, Brear SG, Macartney I, Hammer M, Brenchley PE,. Early cytokine response to multiple injury. Injury 1993; 24: 373-6.
10. Mimasaka S, Funayama M, Hashiyada M, Nata M, Tsunenari S,. Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay. Injury 2007; 38: 1047-51.
11. Partrick DA, Moore FA, Moore EE, Biffl WL, Sauaia A, Barnett CC Jr., Jack A,. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996; 172: 425-9; discussed 429-31.
12. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL,. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997; 25: 1813-9.
13. Endo S, Inada K, Yamada Y, Takakuwa T, Kasai T, Nakae H, Yoshida M, Ceska M,. Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 1994; 22: 949-55.
14. Ferguson KL, Taheri P, Rodriguez J, Tonapi V, Cardellio A, Dechert R,. Tumor necrosis factor activity increases in the early response to trauma. Acad Emerg Med 1997; 4: 1035-40.
15. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC, Abraham E,. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839-45.
16. Biffl WL, Moore EE, Moore FA, Peterson VM,. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996; 224: 647-64.
17. Giannoudis PV, Smith RM, Perry SL, Windsor AJ, Dickson RA, Bellamy MC,. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 2000; 26: 1076-81.
18. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G,. Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma 1993; 35: 698-702.
19. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, van der Meer JW, Goris RJ,. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218: 769-76.
20. Seekamp A, Jochum M, Ziegler M, van Griensven M, Martin M, Regel G,. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 1998; 44: 874-82.
21. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT,. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996; 40: 613-6; discussion 616-7.
22. DiPiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR Jr., Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995; 130: 1159-62; discussion 1162-3.
23. DiPiro JT, Hamilton RG, Howdieshell TR, Adkinson NF Jr., Mansberger AR Jr., Total IgE in plasma is elevated after traumatic injury and is associated with sepsis syndrome. Ann Surg 1992; 215: 460-5; discussion 465-6.
24. Bjornson AB, Altemeier WA, Bjornson HS,. Host defense against opportunist microorganisms following trauma. II. Changes in complement and immunoglobulins in patients with abdominal trauma and in septic patients without trauma. Ann Surg 1978; 188: 102-8.
25. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE,. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986; 121: 1000-5.
26. O'Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH, Mannick JA,. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24: 869-75.
27. Keane RM, Birmingham W, Shatney CM, Winchurch RA, Munster AM,. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 1983; 156: 163-7.
28. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr., Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123: 1309-12.
29. Szabo G, Kodys K, Miller-Graziano CL,. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation. J Clin Immunol 1991; 11: 326-35.
30. Faist E, Schinkel C, Zimmer S, Kremer JP, Von Donnersmarck GH, Schildberg FW,. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 1993; 34: 846-53; discussion 853-4.
31. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA,. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997; 226: 450-8; discussion 458-60.
32. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, Rogers S, Lederer JA, Mannick JA,. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006; 244: 514-23.
33. Murphy TJ, Ni Choileain N, Zang Y, Mannick JA, Lederer JA,. CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 2005; 174: 2957-63.
34. Kelly JL, Lyons A, Soberg CC, Mannick JA, Lederer JA,. Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery 1997; 122: 146-52.
35. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA,. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006; 176: 225-36.
36. Hsieh CH, Frink M, Hsieh YC, Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Chaudry IH,. The role of MIP-1 alpha in the development of systemic inflammatory response and organ injury following trauma hemorrhage. J Immunol 2008; 181: 2806-12.
37. Kawasaki T, Fujimi S, Lederer JA, Hubbard WJ, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH,. Trauma-hemorrhage induces depressed splenic dendritic cell functions in mice. J Immunol 2006; 177: 4514-20.
38. Kobbe P, Vodovotz Y, Kaczorowski DJ, Mollen KP, Billiar TR, Pape HC,. Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture. Shock 2008; 30: 43-7.
39. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM,. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131: 1303-8; discussion 1308-9.
40. Kang SC, Matsutani T, Choudhry MA, Schwacha MG, Rue LW, Bland KI, Chaudry IH,. Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage? Cytokine 2004; 26: 223-30.
41. Wichmann MW, Ayala A, Chaudry IH,. Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 1998; 26: 1372-8.
42. Abraham E, Chang YH,. Cellular and humoral bases of hemorrhage-induced depression of lymphocyte function. Crit Care Med 1986; 14: 81-6.
43. Abraham E, Freitas AA,. Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 1989; 142: 899-906.
44. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH,. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987; 122: 62-8.
45. Morris JA Jr., MacKenzie EJ, Damiano AM, Bass SM,. Mortality in trauma patients: the interaction between host factors and severity. J Trauma 1990; 30: 1476-82.
46. Oberholzer A, Keel M, Zellweger R, Steckholzer U, Trentz O, Ertel W,. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 2000; 48: 932-7.
47. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F,. Gender differences in human sepsis. Arch Surg 1998; 133: 1200-5.
48. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW,. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26: 167-72.
49. Wohltmann CD, Franklin GA, Boaz PW, Luchette FA, Kearney PA, Richardson JD, Spain DA,. A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 2001; 181: 297-300.
50. Choudhry MA, Bland KI, Chaudry IH,. Trauma and immune response-effect of gender differences. Injury 2007; 38: 1382-91.
51. Yokoyama Y, Schwacha MG, Samy TS, Bland KI, Chaudry IH,. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002; 26: 63-76.
52. Burrows L, Tartter P,. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 1982; 2: 662.
53. Okuno K, Ozaki M, Shigeoka H, Nakajima I, Nakamura K, Hirohata T, Jinnai H, Yasutomi M,. Effect of packed red cell and whole blood transfusion on liver-associated immune function. Am J Surg 1994; 168: 340-4.
54. Opelz G, Sengar DP, Mickey MR, Terasaki PI,. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-9.
55. Pirenne J, Kitade H, Kawai M, Koshiba T, Van Damme B, Mathieu C, Waer M,. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005; 79: S25-7.
56. Salvatierra O Jr., Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ,. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543-52.
57. Singal DP, Joseph S,. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol 1982; 4: 93-108.
58. Utter GH, Reed WF, Lee TH, Busch MP,. Transfusion-associated microchimerism. Vox Sang 2007; 93: 188-95.
59. Gianotti L, Pyles T, Alexander JW, Babcock GF, Carey MA,. Impact of blood transfusion and burn injury on microbial translocation and bacterial survival. Transfusion 1992; 32: 312-7.
60. Winslow GA, Shelby J, Nelson EW, Saffle JR,. Influence of allogeneic blood transfusion on natural killer cell activity in burn-injured mice. J Burn Care Rehabil 1996; 17: 117-23.
61. Sullivan DJ, Barton RG, Edelman LS, Shao Y, Nelson EW, Shelby J,. Distinct effects of allogeneic blood transfusion on splenocyte cytokine production after hemorrhagic shock. J Surg Res 1998; 75: 54-60.
62. Golde WT, Gollobin P, Rodriguez LL,. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY) 2005; 34: 39-43.
63. Jackman RP, Utter GH, Heitman JW, Hirschkorn DF, Law JP, Gefter N, Busch MP, Norris PJ,. Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol 2011; 18: 318-26.
64. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B,. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995; 172: 296-301.
65. Perl M, Gebhard F, Knoferl MW, Bachem M, Gross HJ, Kinzl L, Strecker W,. The pattern of preformed cytokines in tissues frequently affected by blunt trauma. Shock 2003; 19: 299-304.
66. Law MM, Cryer HG, Abraham E,. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma 1994; 37: 100-9; discussion 109-10.
67. Grossetete M, Phelps J, Arko L, Yonas H, Rosenberg GA,. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery 2009; 65: 702-8.
68. Ulrich D, Noah EM, von Heimburg D, Pallua N,. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg 2003; 111: 1423-31.
69. Crespo AR, Da Rocha AB, Jotz GP, Schneider RF, Grivicich I, Pinheiro K, Zanoni C, Regner A,. Increased serum sFas and TNFalpha following isolated severe head injury in males. Brain Inj 2007; 21: 441-7.
70. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC,. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. J Neuroimmunol 2002; 122: 167-74.
71. Paunel-Gorgulu A, Flohe S, Scholz M, Windolf J, Logters T,. Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Crit Care 2011; 15: R20.
72. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC,. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab 2010; 30: 769-82.
73. Pincemail J, Deby-Dupont G, Deby C, Thirion A, Torpier G, Faymonville ME, Damas P, Tomassini M, Lamy M, Franchimont P,. Fast double antibody radioimmunoassay of human granulocyte myeloperoxidase and its application to plasma. J Immunol Methods 1991; 137: 181-91.
74. De AK, Kodys KM, Pellegrini J, Yeh B, Furse RK, Bankey P, Miller-Graziano CL,. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression. Clin Immunol 2000; 96: 52-66.
75. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML,. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482-90; discussion 490-2.
76. Puyana JC, Pellegrini JD, De AK, Kodys K, Silva WE, Miller CL,. Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma 1998; 44: 1037-45; discussion 1045-6.
77. Stylianos S, Wakabayashi G, Gelfand JA, Harris BH,. Experimental hemorrhage and blunt trauma do not increase circulating tumor necrosis factor. J Trauma 1991; 31: 1063-7.
78. Wick M, Kollig E, Muhr G, Koller M,. The potential pattern of circulating lymphocytes TH1/TH2 is not altered after multiple injuries. Arch Surg 2000; 135: 1309-14.
79. Asadullah K, Docke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W,. Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol 1999; 135: 187-92.
80. Nuki G, Bresnihan B, Bear MB, McCabe D,. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002; 46: 2838-46.
81. Caron A, Desrosiers RR, Beliveau R,. Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. Exp Cell Res 2005; 310: 105-16.
82. de Vries DK, Lindeman JH, Tsikas D, de Heer E, Roos A, de Fijter JW, Baranski AG, van Pelt J, Schaapherder AF,. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant 2009; 9: 1574-84.
83. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP,. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 1997; 108: 263-8.
84. Kukielka GL, Youker KA, Hawkins HK, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML,. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci 1994; 723: 258-70.
85. Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ,. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb Haemost 2004; 91: 506-13.
86. Proczka RM, Malecki M, Chorostowska-Wynimko J, Polanski JA,. Vascular-endothelial growth factor (VEGF) in patients with peripheral ischemia. J Physiol Pharmacol 2006; 57 Suppl 4: 305-11.
87. Kavathia N, Jain A, Walston J, Beamer BA, Fedarko NS,. Serum markers of apoptosis decrease with age and cancer stage. Aging (Albany NY) 2009; 1: 652-63.
88. Shurin GV, Yurkovetsky ZR, Chatta GS, Tourkova IL, Shurin MR, Lokshin AE,. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007; 39: 123-9.
89. Miller SJ, Watson WC, Kerr KA, Labarrere CA, Chen NX, Deeg MA, Unthank JL,. Development of progressive aortic vasculopathy in a rat model of aging. Am J Physiol Heart Circ Physiol 2007; 293: H2634-43.
90. Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T,. Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 2003; 49: 293-300.
91. Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY,. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004; 18: 320-2.
92. Li L, Smith A, Hagen TM, Frei B,. Vascular oxidative stress and inflammation increase with age: ameliorating effects of alpha-lipoic acid supplementation. Ann N Y Acad Sci 2010; 1203: 151-9.
93. Napolitano LA, Burt TD, Bacchetti P, Barron Y, French AL, Kovacs A, Anastos K, Young M, McCune JM, Greenblatt RM,. Increased circulating interleukin-7 levels in HIV-1-infected women. J Acquir Immune Defic Syndr 2005; 40: 581-4.